Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates

被引:10
|
作者
Julia Ruiz, Maria [1 ]
Salido, Jimena [1 ]
Abusamra, Lorena [2 ,3 ]
Ghiglione, Yanina [1 ]
Cevallos, Cintia [1 ]
Damilano, Gabriel [1 ]
Maria Rodriguez, Ana [1 ,5 ]
Trifone, Cesar [1 ]
Laufer, Natalia [1 ,3 ]
Giavedoni, Luis D. [4 ]
Sued, Omar [2 ,3 ]
Salomon, Horacio [1 ]
Magdalena Gherardi, Maria [1 ]
Turk, Gabriela [1 ]
机构
[1] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Paraguay 2155 Piso 11,C1121ABG, Buenos Aires, DF, Argentina
[2] Fdn Huesped, Buenos Aires, DF, Argentina
[3] Hosp Juan A Fernandez, Unidad Enfermedades Infecciosas, Buenos Aires, DF, Argentina
[4] Texas Biomed Res Inst, Dept Virol & Immunol, Southwest Natl Primate Res Ctr, San Antonio, TX USA
[5] Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab INIGEM, Buenos Aires, DF, Argentina
来源
EBIOMEDICINE | 2017年 / 26卷
基金
美国国家卫生研究院;
关键词
HIV-1; Serodiscordant couples; ADCC; transmission; EXPOSED SERONEGATIVE INDIVIDUALS; T-LYMPHOCYTE RESPONSES; UNINFECTED INDIVIDUALS; MEDIATED CYTOTOXICITY; DISEASE PROGRESSION; PRIMARY INFECTION; EFFECTOR-FUNCTION; MESSENGER-RNA; SEX WORKERS; ANTIBODY;
D O I
10.1016/j.ebiom.2017.11.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As the HIV/AIDS pandemic still progresses, understanding the mechanisms governing viral transmission as well as protection from HIV acquisition is fundamental. In this context, cohorts of HIV serodiscordant heterosexual couples (SDC) represent a unique tool. The present study was aimed to evaluate specific parameters of innate, cellular and humoral immune responses in SDC. Specifically, plasma levels of cytokines and chemokines, HIV-specific T-cell responses, gp120-specific IgG and IgA antibodies, and HIV-specific antibody-dependent cellular cytotoxicity (ADCC) activity were assessed in nine HIV-exposed seronegative individuals (ESN) and their corresponding HIV seropositive partners (HIV+-P), in eighteen chronically infected HIV subjects (C), nine chronically infected subjects known to be HIV transmitters (CT) and ten healthy HIV-donors (HD). Very low magnitude HIV-specific cellular responses were found in two out of six ESN. Interestingly, HIV+-P had the highest ADCC magnitude, the lowest IgA levels and the highest IgG/IgA ratio, all compared to CT. Positive correlations between CD4(+) T-cell counts and both IgG/IgA ratios and % ADCC killing uniquely distinguished HIV+-P. Additionally, evidence of IgA interference with ADCC responses from HIV+-P and CT is provided. These data suggest for the first time a potential role of ADCC and/or gp120-specific IgG/IgA balance in modulating heterosexual transmission. In sum, this study provides key information to understand the host factors that influence viral transmission, which should be considered in both the development of prophylactic vaccines and novel immunotherapies for HIV-1 infection. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:25 / 37
页数:13
相关论文
共 8 条
  • [1] A Role for Fc-Mediated Humoral Immunity in Reducing HIV Transmission Rates between HIV Serodiscordant Heterosexual Couples
    Kent, Stephen J.
    Chung, Amy W.
    EBIOMEDICINE, 2017, 26 : 2 - 3
  • [2] Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses
    Brave, Andreas
    Hallengard, David
    Malm, Maria
    Blazevic, Vesna
    Rollman, Erik
    Stanescu, Ioana
    Krohn, Kai
    VACCINE, 2009, 27 (02) : 184 - 186
  • [3] Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Caninde goats and their potential protection against caseous lymphadenitis
    Moura-Costa, L. F.
    Bahia, R. C.
    Carminati, R.
    Vale, V. L. C.
    Paule, B. J. A.
    Portela, R. W.
    Freire, S. M.
    Nascimento, I.
    Schaer, R.
    Barreto, L. M. S.
    Meyer, R.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 126 (1-2) : 131 - 141
  • [4] Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus
    Khattar, Sunil K.
    Palaniyandi, Senthilkumar
    Samal, Sweety
    LaBranche, Celia C.
    Montefiori, David C.
    Zhu, Xiaoping
    Samal, Siba K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (02) : 504 - 515
  • [5] Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression
    Chuenchitra, T
    Wasi, C
    Louisirirojchanakul, S
    Nitayaphan, S
    Sutthent, R
    Cox, JH
    De Souza, MS
    Brown, AE
    Birx, DL
    Polonis, VR
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (04) : 293 - 305
  • [6] Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines
    Stumpf, Julian
    Klimova, Anna
    Mauer, Rene
    Steglich, Anne
    Gembardt, Florian
    Martin, Heike
    Glombig, Grit
    Frank, Kerstin
    Tonn, Torsten
    Hugo, Christian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (04) : 796 - 798
  • [7] Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus (vol 11, pg 504, 2015)
    Khattar, Sunil K.
    Palaniyandi, Senthilkumar
    Samal, Sweety
    LaBranche, Celia C.
    Montefiori, David C.
    Zhu, Xiaoping
    Samal, Siba K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (04) : 1087 - 1087
  • [8] Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant:: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector
    Gómez, CE
    Rodríguez, D
    Rodríguez, JR
    Abaitua, F
    Duarte, C
    Esteban, M
    VACCINE, 2001, 20 (5-6) : 961 - 971